EFFICACY OF ROSUVASTATIN VERSUS ATORVASTATIN IN PATIENTS WITH DIABETES: RESULTS OF A SUBGROUP ANALYSIS FROM THE POLARIS STUDY

被引：0
|
作者：
Leiter, L. A. [1 ]
Sosef, F. [2 ]
Ycas, J. [3 ]
Melezinkova, H. [4 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Div Endocrinol & Metab, Toronto, ON M5B 1W8, Canada
[2] AstraZeneca, Molndal, Sweden
[3] AstraZeneca, Wilmington, DE USA
[4] AstraZeneca, Macclesfield, Cheshire, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2008年 / 9卷 / 01期
关键词：
D O I：
10.1016/S1567-5688(08)70816-X
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：204 / 204
页数：1
相关论文
共 50 条
  • [21] Effects of rosuvastatin and atorvastatin on non-HDL-C in patients with type 2 diabetes: Results of the ANDROMEDA study
    Betteridge, DJ
    Gibson, M
    DIABETES, 2004, 53 : A227 - A227
  • [22] Comparison of the efficacy and tolerability of rosuvastatin with atorvastatin in patients with hypercholesterolaemia: The discovery Penta study
    Fonseca, FAH
    Marotti, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 107 - 108
  • [23] Efficacy and safety of atorvastatin and rosuvastatin in ischemic heart disease patients: A prospective study
    Maqsood, Mariam
    Sadeeqa, Saleha
    Ahmad, Maqsood
    Afzal, Hafsa
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (07) : 1533 - 1538
  • [24] Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with the metabolic syndrome as defined by the IDF: results from the ECLIPSE Study
    Faergeman, O.
    Sosef, F.
    Duffield, E.
    DIABETOLOGIA, 2006, 49 : 745 - 746
  • [25] Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: Results of the CENTAURUS study
    Lablanche, Jean-Marc
    Leone, Attilio
    Merkely, Bela
    Morais, Joao
    Alonso, Joaquim
    Santini, Massimo
    Eha, Jaan
    Demil, Nacima
    Licour, Muriel
    Tardif, Jean-Claude
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2010, 103 (03) : 160 - 169
  • [26] Efficacy comparison of atorvastatin versus rosuvastatin on blood lipid and microinflammatory state in maintenance hemodialysis patients
    Tian, Jianwei
    Hou, Xiaoyan
    Hu, Liping
    Chen, Ting
    Wu, Kefei
    Cai, Chudan
    Bai, Xiaoyan
    RENAL FAILURE, 2017, 39 (01) : 153 - 158
  • [27] Effect of atorvastatin in patients with metabolic syndrome and type 2 diabetes: Subgroup analysis of the collaborative diabetes study (CARDS)
    Betteridge, D. John
    Szarek, Michael
    DeMicco, David
    Colhoun, Helen
    Neil, Andrew
    Hitman, Graham
    Durrington, Paul
    Fuller, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 386A - 386A
  • [28] Effect of rosuvastatin and atorvastatin on LDL-C and CRP levels in patients with type 2 diabetes: Results of the andromeda study
    Betteridge, D
    Gibson, M
    ATHEROSCLEROSIS SUPPLEMENTS, 2004, 5 (01) : 107 - 108
  • [29] Rosuvastatin versus atorvastatin for secondary prevention in cardiovascular risk patients
    Schanz, Moritz
    Latus, Joerg
    NEPHROLOGIE, 2024, 19 (06): : 370 - 372
  • [30] Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia
    Stein, EA
    Strutt, K
    Southworth, H
    Diggle, PJ
    Miller, E
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (11): : 1287 - 1293
12345